Meridien

Meridien Research is a leading clinical research site network based in Florida that provides comprehensive investigative services to the pharmaceutical, biotechnology, and medical device industries. Founded in 2000, the company operates multiple dedicated research centers specializing in Phase Ib through Phase IV clinical trials across a broad range of therapeutic areas, including neurology, endocrinology, and internal medicine. Meridien Research is recognized for its high patient enrollment rates and expertise in complex indications such as Alzheimer's disease and metabolic disorders. The company was acquired by Avego Healthcare Capital in 2018 and subsequently became part of the Alcanza Clinical Research network, continuing to support global drug development through high-quality data collection and patient-centric trial execution.